Profil
Masaharu Osato worked as a Director at EMI Holding, Inc. from 2015 to 2019, as a Director-Health Screening Centre at Tokyo Adventist Hospital from 1993 to 1997, as an Independent Director at Emmaus Life Sciences, Inc. from 2019 to 2022, and as a Director-Health Screening Centre at Kobe Adventist Hospital from 1988 to 1993.
Anciens postes connus de Masaharu Osato
| Sociétés | Poste | Fin |
|---|---|---|
| EMMAUS LIFE SCIENCES, INC. | Director/Board Member | 28/09/2022 |
EMI Holding, Inc.
 EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | Director/Board Member | 22/07/2019 |
| Tokyo Adventist Hospital | Corporate Officer/Principal | 01/01/1997 |
| Kobe Adventist Hospital | Corporate Officer/Principal | 01/01/1993 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EMMAUS LIFE SCIENCES, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | Health Technology |
| Tokyo Adventist Hospital | |
| Kobe Adventist Hospital |
